| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |